IM R3 박미나 Case conference. 11587858 마 0 희 (F/34) ADM. 2005.10.23 C.C: easy bruising P.I: 2002 년 1 월 AML M2 진단 후 AI induction, AI consolidation #1-2 시행.

Slides:



Advertisements
Similar presentations
台北榮總血液腫瘤科 楊元豪 / 高志平大夫. 2 Background Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only potentially curative treatment in patients.
Advertisements

Leukemia & Lymphoma Keith Rischer, RN, MA, CEN. Leukemia Patho Loss of regulation in cell division, causes proliferation of malignant leukocytes Classification.
5-Azacitidine For Myelodysplasia Before Allogeneic Hematopoietic Cell Transplantation Field T et al. Bone Marrow Transplant 2009:[Epub ahead of print].
DONOR LYMPHOCYTE INFUS I ON (DLI) Dr. Serdar ŞIVGIN February 2011 Kayseri.
Single-Agent Lenalidomide Induces Complete Remission of Acute Myeloid Leukemia in Patients with Isolated Trisomy 13 Fehniger TA et al. Blood 2009;113(5):
Treatment. Phases of treatment Induction chemotherapy Postremission therapy *Initial goal: quickly induce CR *Therapy depends on patient age.
CASE 경희 의료원 소화기 내과 황보 영. 방 O 극 (M/20) adm ; Epigastric discomfort o/s) remote; 수개월전 recent; 수일전 상기 환자는 anal bleeding 으로 국군대전병원 외래 내원 하여 anal hemorrhoids.
Echo conference R1 하 상 진 박 * 순 (F/69) Admission date Patient’s history Chief complaint : chest pain onset) 내원 30 분전 Character: sqeezing.
Medical Grand Round 순환기 내과 R2 송 란 박 0 돌 (F/70) Adm C.C. : chest pain onset - 일주일 전 duration – 10 분이내 site – substernal area frequency.
M G R Acute A viral hepatitis CASE 1 R2 이은정 / R4 박재현 / prof 김병호.
우연히 발견된 폐결절환자 증례 호흡기내과 R1 최윤영/ Prof. 박명재
MGR Division of pulmonary and critical care medicine Department of Internal Medicine, Kyung Hee University College of Medicine R1 김은영.
갑작스런 호흡부전을 주소로 내원한 75 세 여자환자 Department of pulmonolgy R1. lee jung hoon/ prof. park myung jea Case Conference.
순환기내과 R1 윤경한 / Prof. 한미영 Medical Grand Rounds Case Presentation.
호흡 곤란을 주소로 내원한 44 세 여자 환자 호흡기 내과 R1 이지훈 / Prof. 박명재.
Case Conference 신장내과 R2 최소영 박 O 주 (M/82) adm : C.C) Fevero/s 1 weeks ago P.I ) M/82 30 년전 HTN, 3 년전 Old CVA, BPH Dx, 04 년 APN 으로 입원.
박 O 호, M/24 병록번호 : Admission: C.C. fever o/s)2 주 전 P.I. 특이병력 없는 자로 내원 2 주 전부터 fever 발생하였고, 6 일 전부터 anorexia, watery diarrhea 발생하여.
Case of the Week `R1 유태경. CASE 1 발열을 주소로 내원한 49 세 여자.
Case Conference 내분비 대사 내과 R1 우용식. 양수희 ( F/59 ) adm : Chief complain sweatingoneset – 3 yrs ago; gradually intermittent Present illness.
Case Conference Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University College of Medicine, Seoul, Korea R2 임효석 / Prof. 장재영.
1 MGR 내분비 대사 내과 R2 황연희. 2 주소 전신적인 무기력증 발병시기 : 약 7 개월 전 현병력 특이 병력과 약물 복용력 없는 62 세 여자 환자로 7 개월 전부터 쉽게 지치고, 일상생활 유지 못할 정도로 전신 무기력감 지속되어 건강검진 시행 받았으며 당시 혈청.
Case presentation IG R2 소예리 / Prof. 김병호 원 O 근 M/52 Adm on Chief complaint abdominal pain Present illness M/52, 2010 년 1 월 B-viral.
Case Presentation Division of Gastroenterology R2 김 지 연.
MGR 혈액종양내과 이 O 예 (F/76) ADM C.C) 구강내출혈 o/s) 2 일전 P.I) 평소 출혈성 경향 보이지 않던 환자로 내원 20 일전 부터 멍이 잘 생기는 증상 있었고 2 일 전부터 구강내출혈 있어.
Daunorubicin VS Mitoxantrone VS Idarubicin As Induction and Consolidation Chemotherapy for Adults with Acute Myeloid Leukemia : The EORTC and GIMEMA Groups.
건강 검진에서 발견된 위선종 73/M 소화기 내과 R 3 김혁 / Prof. 장영운 MGR.
Medical Grand Round 순환기 내과 R1 이윤정. Chief complaint Chest pain onset) 내원 30 분전 양상 : 2nd attack ( 1 st : 2000 년, 2 nd : 내원 30 분전 ) character – squeezing.
Acute lymphoblastic leukemia in children
AML Clinical Presentation. Clinical Presentation: Symptoms Fatigue (50%) Anorexia and weight loss Fever with or without an identifiable infection (10%)
Tumor board 소화기 Case C.C.) For anemia evaluation P.I.) 고혈압으로 본원 순환기내과 F/U 중인 자로 routine lab 상 Hb 13.1g/dL('08 년 4 월 ) ==> 10.9g/dL 감소 동반한.
신장 내과 R2 서정호 Case conference. 김 O 원 (F/26) adm : adm via ER C.C ) abdominal pain o/s)1day P.I ) 97 년부터 Lupus nephritis (type IV) 로.
Case of the week 신장내과 R2 이재연.
Polygrandular Autoimmune Syndrome 내분비대사 내과 R1 권성진.
Case of Week Department of Gastroenterology 이윤정. Chief complaint Sore throat ( onset : 2weeks ago ) Present illness Present illness 특이병력 없는 26 세 남자환자로.
MGR - case R2. 유정선 / Prof. 정재헌. Case 송 O 섭 M/67 Adm date: Chief complaint Left neck mass o/s) 15 일전 Present illness 67/M, 2009.
Problem case Dep. Of Nephrology R1. Choi In-Ah arteriovenous graft site 의 redness 와 swelling 을 주소로 내원한 52 세 남성.
Case Conference 신장내과 R2 우종신 한스 0 자 (F/69) adm : CC ) Poor oral intake (onset: 15days ago) P.I ) 2005 년 12 월 TKR Rt 받은 Hx 있는 자로, 당시 Cr.
Case of Week 감염면역 내과 Prof. 이미숙 / R2 이윤정. Chief complaint Rt. Facial pain onset) 내원 10 일전 Present illness 특별한 medical Hx. 와 약물 복용력 없는 63 세 여자 환자로 내원 10.
Case presentation 소화기내과 R1 손주웅 / Prof. 동석호. 김 O 덕 (M/45) adm :  C.C : Abd. pain o/s) 내원 약 3 주전  Present illness  6 개월 전부터 2 형 당뇨병으로.
종양표지자 상승으로 의뢰된 51 세 자궁평활근육종 환자 국립암센터 위암센터 이종열 제 86 회 대한소화기내시경학회 월례집담회.
조절되지 않는 혈당을 주소로 내원한 44 세 남자 환자 경희의료원 내분비 내과 R2. 이정훈 / prof. 우정택 1.
M G R Two Cases of Superficial esophageal neoplasm CASE 1 R1 이은정 / R3 조창현 / prof 장재영.
Care of Relapsed Breast Cancer MGR R2 황은정 /prof. 김시영.
신장내과 R3 김경엽 Case Conference 김 0 화 (F/46) 입원 2006 년 7 월 23 일 CC: for KTP PI: 1988 년 nephrotic syndrome 있었으나 renal biopsy 시 행하지 않고 지내다가 CRF 발생하여.
Chief Complaint 백혈구 증가 onset : 내원 1 주 전 Present Illness 04 년 8 월 AML M4 진단. High dose Ara-C+ Idarubicine 항암치료 후 complete remission. Pneumonia 로 vetilator.
Case Conference Department of nephrology R2 우용식 유 O 형 (M/69) adm: C. C. : headache, fever o/s- 4 주전 P. I. :  M/69, 9 월초 headache,
Echo- Conference R2 조경민. History 강 O 은 (F/77) Chief Complaint Chief Complaint Chest pain o/s) On the day hospitalization Chest pain o/s) On the.
Echo-Conference R2 조경민. History 박 O 화 (F/31) Chief Complaint Chief Complaint Fever.chilling & Chest discomfort O/S) 10 days ago Fever.chilling.
Case I. Chief complain : dyspnea o/s) 2 days ago Present illness : a 67 years old man with hypertension, MVP and atrial fibrillation had taken medicine.
Case Presentation Jung Hyun Seo Department of Internal Medicine Catholic University of Daegu School of Medicine School of Medicine.
Case II. Chief complain : RUQ pain o/s) 2 days ago Present illness : a 45 years old woman with hypertension and ASD had taken medicine at local clinic.
MGR Cough를 주소로 내원한 젊은 여자 2례 호흡기 내과 R1 정수웅/Prof. 박명재.
Department of oncology. C/C Poor oral intake, abdominal distension (onset: 2 weeks ago) P/H DM (+): detection, medication 중 HTN/Hepatitis/Tuberculosis.
MGR Department of Pulmonology Prof. 박명재 /R1 조용덕.
Echo-Conference R2 조경민. History 송 O 규 Chief Complaint Lt.side weakness O/S) Recent onset 3-4 days ago Present illness A 75 year old woman had.
소화기 내과 R2 박정은 M G R 한 0 협 (M/11) adm) Chief complaint known abnormal LFT Present illness 11 세 남자환자로 1 년 전 학교에서 시행한 혈액검사에서 AST/ALT 227/283.
R3 이정훈 Echo Conference. History 임 O 수 (M/45) adm. Via OPD Chief Complaint dyspnea of exertion o/s) 1yr ago dyspnea of exertion o/s)
Case ( ) TACE 시술 후 발생한 Acute Renal Failure 소화기내과 R2 진상욱.
M.G.R 혈액종양내과 R2 윤현아 /prof. 백선경 Neck mass 를 주소로 온 환자.
Angio Conference 김 O 동 (M/50) Admission: Chief complaint - Chest Pain (recent o/s: 내원 2 주전, remote o/s: 내원 1 년전 ) squeezing type Ant.
GS – GI – RAD - PATH Conference
Case Conference 신장내과 R2 최소영 조 O 순 (F/71) adm : C.C) Evaluation of proteinuria P.I ) 10 년전 DM, HTN 진단 투약중인 자로 발생한 Left side weakness.
Case conference IM R3 박미나.
GI-GS-RAD.-PATH. conference
Autologous PBSCT of Multiple myeloma
손발 커짐을 주소로 내원한 48세 여자환자 내분비대사 내과 R3 정명화/ Prof. 김성운.
Case presentation 경희의료원 내과 R2 조창현.
Case conference 감염내과 R2 문수연.
Department of Gastroenterology
Case Presentation 2010/ 03/15.
Presentation transcript:

IM R3 박미나 Case conference

마 0 희 (F/34) ADM C.C: easy bruising P.I: 2002 년 1 월 AML M2 진단 후 AI induction, AI consolidation #1-2 시행 후 complete remission 되었으나 그 후 f/u loss 되었던 환자 년 7 월 AML relapse 발견되어 AI induction, AI consolidation#1 후 2005 년 2 월 allogenic BMT(donor: 언니 ) 시행함. 그 후 외래에서 cyclosporin 복용하며 f/u 해오던 중 최근 easy bruising 있으며 일반 혈액 검사에서 혈소판 감소 양상 심화되어 자세한 검사 위해 입원 PMHx: DM/HTN/Tbc/hepatitis(-/+/-/-) op Hx (-) FHx: none, PHx: alcohol(-) smoking(-)

Review of system weight loss(-), fever sense(-), chill(-), fatigue(+) sweating(-) rash(-), itching(-), multiple petechia (+) headache(-), gum bleeding(-), sore throat(-) cough(-), sputum(-), hemoptysis(-) chest pain(-), palpitation(-), edema(-), dyspnea(-) A/N/V/D/C(+/-/-/-/-), jaundice(-), melena(-) frequency(-), dysuria(-), hematuria(-) dizziness(+), tremor(-), syncope(-)

Physical examination 120/ 회 /min-20 회 /min-36.3°C Alert mentality, chronic ill appearence Multiple petechia on both extremity and ant.chest wall Pale conjunctiva, clear sclera No neck vein engorgement, no cervical LN enlargement CBS without crackle, RHB without murmur soft and flat abdomen, no hepatosplenomegaly no abdominal T/RT, normoactive bowel sound No pph pitting edema, no CVA tenderness

Laboratory finding CBC/DC 1420/mm g/dl –17.1 % -7K/mm 3 (seg: 54%, lympho 42%, mono 2%) (MCV fl, MCH 36.4pg) Chemistry T/D bil 0.5/0.0mg/dL AST/ALT 41/42 U/L T-prot/Alb 6.1/3.9g/dL ALP/rGT 183/38 U/L BUN/Cr 5/0.6mg/dL Na/K/Cl 139/3.6/103 mEq/L Glucose 115mg/dL LD/CK 551/51U/L Ca /Mg /P /uric acid 8.6/2.7/3.1/3.9 mg/dL Cyclo ng/mL( )

Chest X-ray

Old chart review BM: AML M2 (blast 42%) FISH : AML1/ETO (+), Chromosome: t(8:21)(q22:q22.2) BM: Treated AML (blast 1.2%) FISH : AML1/ETO (+), Chromosome: No cytogenic abNL BM: AML remission (blast 0.5%) FISH : AML1/ETO (+), Chromosome: No cytogenic abNL AI induction Ara-C (D1-7)+ Idarubicin (D1-3) AI consolidation#1 Ara-C (D1-5)+ Idarubicin (D1-3) ID Ara-C (D1-5)

04.3. BM: AML M2 relapse (blast 38%) FISH : AML1/ETO (+), Chromosome: t(8:21)(q22:q22.2) BM: AML M2 remission (blast 1.4%) FISH : AML1/ETO (+), Chromosome: t(8:21)(q22:q22.2) BM: Treated AML remission FISH : AML1/ETO (-), Chromosome: No cytogenic abNL AI induction Ara-C (D1-7)+ Idarubicin (D1-3) AI consolidation#1 Ara-C (D1-5)+ Idarubicin (D1-3)

BM: Engraft of tri-lineage cells(post BMT 39 days) FISH : AML1/ETO (-), Chromosome: no cytogenic abNL mixed chimerism (1.6% 미만 ) Cyclosporin 200/100mg, 100mg, 100/50mg po ( ng/Ml) 복용하며 OPD F/U Allogenic bone marrow transplantation

날짜 WBC(mm 3 )Hgb(g/dl)PLT(mm 3 )Dfferential count 3/ KSeg82.4% 4/ KSeg65.3% 5/ KSeg63.8% 6/ KSeg67% 7/ KSeg60.7% BM: Post BMT state in remission FISH : AML1/ETO (-), Chromosome: no cytogenic abNL complete chimerism (0.8%)

날짜 WBC(mm 3 )Hgb(g/dl)PLT(mm 3 )Dfferential count 3/ KSeg82.4% 4/ KSeg65.3% 5/ KSeg63.8% 6/ KSeg67% 7/ KSeg60.7% 8/ KSeg44%, Lymph 48% 9/ KSeg34%, Lymph 62% 9/ KSeg40%, Lymph 51%

Bone marrow exam ( )

Bone marrow exam ( ) Blast : 23.6%, cellularity : 70% => Post BMT state of acute myelogenous leukemia (FAB M2) in relapse Chromosome study with BM: 46XX,t(8:21),(q22:q22) /46,XX FISH:AML/ETO rearrangement-> positive (15.1%)

날짜 WBC(mm 3 )Hgb(g/dl)PLT(mm 3 )Dfferential count 9/ KSeg51%, Lymph 44% 9/ KSeg61.2%, Lymph 27.2% 10/ KSeg43%, Lymph 52% 10/ KSeg20%, Lymph 78% 10/ KSeg16%, Lymph 77% 10/ KSeg16%, Lymph 79% 10/ KSeg25%, Lymph 70%

AML M2 in relaspe (s/p allogenic BMT) AI induction Donor lymphocyte infusion

Review < Treatment of AML in relapse after hematopoietic cell transplantation>

Therapy of newly diagnosed AML Induction therapy Cytarabine+anthracycline CR No CR Consolidation#1 Cytarabine+anthracycline Consolidation#1 Cytarabine+anthracycline High dose Ara-C Consolidation#2 Cytarabine+anthracycline High dose Ara-CAuto PBSCT Consolidation#1 Cytarabine+anthracycline Allo BMT Induction therapy Cytarabine+anthracycline Good Px group Intermediate, poor Px group

Induction therapy 60-70% => complete remission Without futher therapy: almost relapse Induction + consolidation therapy Prevent relapse, prolong survival 30% pts long term survival Rarely cure with standard chemotherapy Allogenic SCT : rescue 20% of relapsed pts with AML Poor outcome (early relapse) => new agents

10-36% of pts in acute leukemia ~70% in advanced disease, reveiving T-depleted grafts Selection of pts, timing of transplantation, type of conditioning regimen Median survival : 3-4 months if no futher Tx

Immunosuppressive agents stop Reinduction chemotherapy Second HCT DLI (Donor lymphocyte infusion) Cessation of immunosuppressive agents (cyclosporin) immunomodulator agents (IFN- , IL-2) Conventional or hIgh dose chemotherapy : 30-40% remission, but short duration, most relapse and die

Long term disease free survival in selected pts 2yr survival: 2-25%, long term survival: 10-35% Tx related mortality 25-50%, relapse rate: 40-65% Poor outcome short interval (HCT~relapse (1yr)) GVHD after 1 st transplant, older age, poor performance status, no remission at 2 nd allograft Only responding reinduction (usually 2 nd transplant GVHD prophylaxis ↓ to maximize GVL effect Reduce intensity conditioning FLAG (fludarabine+high dose Ara-C, GCSF) : median duration of 2 nd CR 14months

Discontinuation of immunosuppression -> reinfusion, activation of cytotoxic T lymphocytes of donor GVL effect -> destroying leukemic clone Ratio of difference of minor histocompatibility antigens expression between donor and pts Remission in 20-30% of AML pts after allogenic BMT (75% in CML, 40% in MDS, 15% in myeloma) 2yr survival: 19%, Tx related mortality 23% Major problem: GVHD(30-80%), marrow aplasia

Treatment of relapsed AML after allogeneic BMT with chemotherapy followed by G-CSF-primed DLI Leukemia (2004) 18 Cytoreductive chemotherapy -> G-CSF-primed DLI 2-yr overall survival: 31% CR rate Chemo DLI: DLI= 42-63%: 15-29% Post-BMT remission duration : only significant prognostic factor for overall survival High incidence of isolated extramedullary relapse